ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 791,79
0,64%
Dow Jones
42 283,97
0,26%
DAX
19 473,63
1,32%
Brent Oil
71,645
0,98%
Bitcoin
65 629,66
0,69%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) Actualités

PSNL

Personalis (PSNL)

Personalis Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PSNL
DateHeureSourceTitreSymboleSociété
19/09/202423h28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
16/09/202415h00Business WireESMO 2024 Data Expands on Compelling Performance of Personalis NeXT Personal® MRD TestNASDAQ:PSNLPersonalis Inc
12/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
30/08/202422h43Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
22/08/202422h01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
20/08/202422h27Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:PSNLPersonalis Inc
20/08/202422h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
19/08/202422h05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
16/08/202414h30Business WirePersonalis and Tempus Announce Expanded CollaborationNASDAQ:PSNLPersonalis Inc
07/08/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/08/202422h01Business WirePersonalis Reports Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
06/08/202422h05GlobeNewswire Inc.Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%NASDAQ:PSNLPersonalis Inc
31/07/202422h01Business WirePersonalis to Participate at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceNASDAQ:PSNLPersonalis Inc
24/07/202422h01Business WirePersonalis to Announce Second Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
11/07/202415h00GlobeNewswire Inc.Myriad Genetics and Personalis Cross-License Foundational MRD Intellectual Property to Broaden Patient Access to TestingNASDAQ:PSNLPersonalis Inc
18/06/202422h01Business WirePersonalis to Participate at the TD Cowen 3rd Annual Tools / Dx Revolution ConferenceNASDAQ:PSNLPersonalis Inc
13/06/202414h00Business WirePersonalis Provides Dial-in and Updated Date for ASCO Highlights Conference CallNASDAQ:PSNLPersonalis Inc
04/06/202422h05Business WireASCO Data Highlights NeXT Personal® Ultra-sensitive MRD Performance in Early-stage Breast Cancer Recurrence Detection and Immunotherapy MonitoringNASDAQ:PSNLPersonalis Inc
31/05/202415h05Business WirePersonalis Announces Start of Cancer MRD Testing Commercialization Collaboration with TempusNASDAQ:PSNLPersonalis Inc
22/05/202415h05Business WirePersonalis Announces Podium Presentations and Abstracts Accepted at ASCO 2024NASDAQ:PSNLPersonalis Inc
08/05/202422h01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
24/04/202422h01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202421h01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202414h00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202414h00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
28/02/202422h01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
14/02/202422h01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
30/01/202415h00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
16/01/202415h05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
 Showing the most relevant articles for your search:NASDAQ:PSNL

Dernières Valeurs Consultées

COIN
GGENETH
GemeGen
LSE
AN65
Citi Fun 29
ASX
TAMR
BIT
F17719
Vontobel Financial Produ...
TG
0GZG
BNP Paribas Arbitrage Is...
USOTC
FRFLF
FRNT Financial (QB)
TG
1MS
Munters Group AB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés